Table 1 Comparison of clinicopathologic characteristics according to the Gli1 expression in GA

Age (years)

1.448

0.093

0.229

 < 65

109

32(29.4)

77(70.6)

 ≥ 65

60

13(21.7)

47(78.3)

Sex

1.347

0.246

 Male

106

25(23.6)

81(76.4)

 Female

63

20(31.7)

43(68.3)

Tumor size (cm)

0.759

0.065

0.384

 < 4.5

63

19(30.2)

44(69.8)

 ≥ 4.5

106

26(24.5)

80(75.5)

Tumor grade

15.771

0.049

0.001*

 Well

31

14(45.2)

17(54.8)

 Moderate

66

11(16.7)

55(83.3)

 Poor

72

20(27.8)

52(72.2)

Tumor location

1.943

0.024

0.584

 Antrum

93

23(24.7)

70(75.2)

 Cardia

3

0(0)

3(100.0)

 Body

63

20(31.7)

43(68.3)

 Mix

10

2(20.0)

8(80.0)

pT stage

9.034

0.218

0.029*

 1

35

16(45.7)

19(54.3)

 2

38

11(28.9)

27(71.1)

 3

92

17(18.5)

75(81.5)

 4

4

1(25.0)

3(75.0)

Lymph node metastasis

1.949

0.105

0.163

 Negative

144

41(28.5)

103(71.5)

 Positive

25

4(16.0)

21(84.0)

Distant metastasis

7.403

0.208

 Negative

151

45(29.8)

106(70.2)

 Positive

18

0(0)

18(100.0)

Clinical stage

12.799

0.262

0.005*

 1

44

18(40.9)

26(59.1)

 2

34

11(32.4)

23(67.6)

 3

73

16(21.9)

57(78.1)

 4

18

0(0)

18(100.0)

Gross type

5.365

0.177

0.021*

 Early gastric cancer

37

16(43.2)

21(56.8)

 Advanced gastric cancer

132

29(22.0)

103(78.0)

Histological type

0.389

0.032

0.823

 Intestinal

91

26(28.6)

65(71.4)

 Diffuse

70

17(24.3)

53(75.7)

 Mix

8

2(25.0)

6(75.0)

Survival

23.883

0.375

< 0.001*

 Die

78

7(9.0)

71(91.0)

 Alive

91

38(41.8)

53(58.2)